Allspring Global Investments’s Cymabay Therapeutics CBAY Stock Holding History

Allspring Global Investments’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-80,029	Closed	-$1.89M	–	2446
2023 Q4	$1.89M	Buy	+80,029	New	+$1.43M	﹤0.01%	1194

Other funds holding CBAY

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Allspring Global Investments's CBAY Position: Q1 2024 in Review

Allspring Global Investments sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 80,029 shares — an estimated $1.89M sold.

Allspring Global Investments first reported a position in CBAY in Q4 2023 and held it in 1 quarter. The position peaked at $1.89M in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

Allspring Global Investments reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
Allspring Global Investments sold 80,029 Cymabay Therapeutics shares in Q1 2024, an estimated $1.89M.
Allspring Global Investments first reported a position in Cymabay Therapeutics in Q4 2023 and held it in 1 quarter.
Allspring Global Investments's Cymabay Therapeutics position peaked at $1.89M in Q4 2023.
1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Allspring Global Investments's 13F filing for Q1 2024, filed 18 Apr 2024.